• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环p53抗体作为口腔癌的早期标志物:与p53改变的相关性

Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.

作者信息

Ralhan R, Nath N, Agarwal S, Mathur M, Wasylyk B, Shukla N K

机构信息

Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi.

出版信息

Clin Cancer Res. 1998 Sep;4(9):2147-52.

PMID:9748133
Abstract

p53 aberrations are early events in the pathogenesis of betel- and tobacco-related oral malignancies. Accumulation of p53 protein in oral lesions may elicit a humoral immune response against p53 protein in these patients. p53 antibodies (Abs) were analyzed in 183 sera obtained from patients with premalignant or malignant oral lesions and normal individuals by enzyme-linked immunoassay using recombinant p53 protein as antigen. These results were correlated with accumulation of p53 protein in patients' matched oral tissue specimens. Circulating p53 Abs were observed in 24 of 70 (34%) cancer patients and 15 of 50 (30%) patients with premalignant oral lesions. p53 Abs showed a significant association with increase in tumor size and dedifferentiation of tumors, factors indicative of poor prognosis. Expression of p53 protein was analyzed in 43 matched oral lesions (18 premalignant and 25 malignant cases). All the p53-seropositive patients (7 leukoplakia and 11 squamous cell carcinoma) showed elevated levels of p53 protein in matched oral lesions. However, the total number of patients seropositive for p53 Abs was lesser than that of patients exhibiting p53 protein accumulation in oral lesions. Four of the 63 normal healthy individuals who were heavy consumers of tobacco (smoking/chewing) and betel were found to be positive for p53 Abs. Detection of circulating p53 Abs in patients with premalignant oral lesions suggests that humoral immune response against p53 protein is an early event in oral oncogenesis and may be a surrogate marker for both p53 alteration and preclinical cancer.

摘要

p53畸变是槟榔和烟草相关口腔恶性肿瘤发病机制中的早期事件。口腔病变中p53蛋白的积累可能会引发这些患者针对p53蛋白的体液免疫反应。通过使用重组p53蛋白作为抗原的酶联免疫吸附测定法,对183份来自口腔癌前或恶性病变患者及正常个体的血清进行了p53抗体(Abs)分析。这些结果与患者匹配的口腔组织标本中p53蛋白的积累情况相关。在70例癌症患者中有24例(34%)以及50例口腔癌前病变患者中有15例(30%)检测到循环p53 Abs。p53 Abs与肿瘤大小增加和肿瘤去分化显著相关,这些因素表明预后不良。对43例匹配的口腔病变(18例癌前病变和25例恶性病变)进行了p53蛋白表达分析。所有p53血清阳性患者(7例白斑和11例鳞状细胞癌)在匹配的口腔病变中均显示p53蛋白水平升高。然而,p53 Abs血清阳性患者的总数少于口腔病变中出现p53蛋白积累的患者。在63名大量吸烟/咀嚼烟草和槟榔的正常健康个体中,有4例p53 Abs呈阳性。在口腔癌前病变患者中检测到循环p53 Abs表明,针对p53蛋白的体液免疫反应是口腔肿瘤发生的早期事件,可能是p53改变和临床前癌症的替代标志物。

相似文献

1
Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.循环p53抗体作为口腔癌的早期标志物:与p53改变的相关性
Clin Cancer Res. 1998 Sep;4(9):2147-52.
2
Serum anti-p53 antibodies as a diagnostic tumor marker: observations in patients with malignant and premalignant oral cavity lesions.血清抗p53抗体作为一种诊断性肿瘤标志物:对口腔恶性和癌前病变患者的观察
Minerva Stomatol. 2010 May;59(5):233-9, 239-43.
3
Anti-p53 and anti-heat shock proteins antibodies in patients with malignant or pre-malignant lesions of the oral cavity.口腔恶性或癌前病变患者体内的抗p53抗体和抗热休克蛋白抗体
Anticancer Res. 2001 Jan-Feb;21(1B):753-8.
4
p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.口腔黏膜基底细胞层以上的p53表达是恶性转化的早期事件,对口腔鳞状细胞癌的发生具有预测价值。
J Pathol. 1998 Apr;184(4):360-8. doi: 10.1002/(SICI)1096-9896(199804)184:4<360::AID-PATH1263>3.0.CO;2-H.
5
Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.血清p53抗体是食管浅表鳞状细胞癌中一种有用的肿瘤标志物。
Cancer. 2000 Oct 15;89(8):1677-83.
6
Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.人口腔癌中生存素和p53的检测:与临床病理结果的相关性
Head Neck. 2009 Aug;31(8):1039-48. doi: 10.1002/hed.21071.
7
The detection of quantitative serum p53 protein in lung cancer.肺癌患者血清中p53蛋白定量检测
Tuberk Toraks. 2005;53(3):231-7.
8
Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.三种肝炎标志物(p53抗体、血管内皮生长因子和甲胎蛋白)在肝细胞癌患者中的预后意义。
Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1417-24.
9
Serum p53 antibodies in patients with oral lesions: correlation with p53/HSP70 complexes.口腔病变患者血清中的p53抗体:与p53/HSP70复合物的相关性
Int J Cancer. 1997 Dec 19;74(6):609-13. doi: 10.1002/(sici)1097-0215(19971219)74:6<609::aid-ijc9>3.0.co;2-y.
10
Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.慢性阻塞性肺疾病患者血清中的抗p53抗体可能在癌症诊断之前就已出现。
Clin Cancer Res. 1996 Oct;2(10):1767-75.

引用本文的文献

1
Tumor diagnosis using carbon-based quantum dots: Detection based on the hallmarks of cancer.基于碳基量子点的肿瘤诊断:基于癌症特征的检测
Bioact Mater. 2023 Nov 15;33:174-222. doi: 10.1016/j.bioactmat.2023.10.004. eCollection 2024 Mar.
2
Identification of novel tumor-associated antigens and evaluation of a panel of autoantibodies in detecting oral cancer.鉴定新型肿瘤相关抗原并评估一组自身抗体在检测口腔癌中的应用。
BMC Cancer. 2023 Aug 28;23(1):802. doi: 10.1186/s12885-023-11247-w.
3
Predictive value of tissue p53 protein expression and serum p53 antibodies in oral potentially malignant disorders: Relative to oral squamous cell carcinoma.
组织p53蛋白表达和血清p53抗体在口腔潜在恶性疾病中的预测价值:相对于口腔鳞状细胞癌
J Taibah Univ Med Sci. 2021 Dec 31;17(3):415-423. doi: 10.1016/j.jtumed.2021.11.008. eCollection 2022 Jun.
4
Detection of anti-p53 autoantibodies in saliva using microfluidic chips for the rapid screening of oral cancer.使用微流控芯片检测唾液中的抗 p53 自身抗体以快速筛查口腔癌。
RSC Adv. 2018 Apr 24;8(28):15513-15521. doi: 10.1039/c7ra13734f. eCollection 2018 Apr 23.
5
Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies.针对 p53 突变癌症的有前途的新工具:体液和基于细胞的免疫疗法。
Front Immunol. 2021 Aug 13;12:707734. doi: 10.3389/fimmu.2021.707734. eCollection 2021.
6
Mutant p53 as an Antigen in Cancer Immunotherapy.突变型p53作为癌症免疫治疗中的一种抗原。
Int J Mol Sci. 2020 Jun 8;21(11):4087. doi: 10.3390/ijms21114087.
7
Antibodies specific for disease-associated antigens (DAA) expressed in non-malignant diseases reveal potential new tumor-associated antigens (TAA) for immunotherapy or immunoprevention.针对非恶性疾病中表达的疾病相关抗原 (DAA) 的抗体揭示了潜在的新的肿瘤相关抗原 (TAA),可用于免疫治疗或免疫预防。
Semin Immunol. 2020 Feb;47:101394. doi: 10.1016/j.smim.2020.101394. Epub 2020 Apr 6.
8
Anti-p53 Autoantibody Detection in Automatic Glass Capillary Immunoassay Platform for Screening of Oral Cavity Squamous Cell Carcinoma.在自动玻璃毛细管免疫分析平台上检测抗 p53 自身抗体,用于筛查口腔鳞状细胞癌。
Sensors (Basel). 2020 Feb 11;20(4):971. doi: 10.3390/s20040971.
9
Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors.非功能性胰腺神经内分泌肿瘤中新型抗EID3血清自身抗体的鉴定
Oncotarget. 2017 Oct 31;8(63):106206-106221. doi: 10.18632/oncotarget.22175. eCollection 2017 Dec 5.
10
Oncoapoptotic markers in oral cancer: prognostics and therapeutic perspective.口腔癌中的肿瘤凋亡标志物:预后及治疗前景
Mol Diagn Ther. 2014 Oct;18(5):483-94. doi: 10.1007/s40291-014-0104-5.